Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
Yaodan Bi, Yingchao Zhu, Shuai Tang, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Genetics of migraine: complexity, implications, and potential clinical applications
Heidi G. Sutherland, Bronwyn Jenkins, Lyn R. Griffiths
The Lancet Neurology (2024) Vol. 23, Iss. 4, pp. 429-446
Closed Access | Times Cited: 14
Identifying novel proteins for migraine by integrating proteomes from blood and CSF with genome‐wide association data
Peng‐Peng Niu, Rui Zhang, Chan Zhang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 6
Open Access | Times Cited: 5
The association between Lipid accumulation products and Migraine Risk : results from the 1999-2004 NHANES analysis
Shiqiang Yang, Yanwei Liu, Shi‐Qiang Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Lipids, lipid-lowering drug target genes and pancreatic cancer: a Mendelian randomization study
Yuxuan Zhan, Kai Zhang, Yiqun Fan, et al.
International Journal of Clinical Pharmacy (2025)
Open Access
Conventional and genetic association between migraine and stroke with druggable genome-wide Mendelian randomization
Xiaoyu Wang, Wendu Pang, Xin Hu, et al.
Human Genetics (2025)
Closed Access
Genetic Insights Into Lipid Traits and Lipid-Modifying Drug Targets in Pregnancy Complications: A Two-Sample Mendelian Randomization Study
Huijing Shao, Chang Xu, Caihong Zhang, et al.
International Journal of Women s Health (2025) Vol. Volume 17, pp. 221-234
Open Access
Exploring the association between statins use or HMG-CoA reductase inhibition and migraine: a systematic review and meta-analysis
Hamdy A. Makhlouf, Amr K. Hassan, Nereen A. Almosilhy, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Genetic Association of Lipids and Lipid-Lowering Drug Target Genes With Attention Deficit Hyperactivity Disorder
Detong Guo, Wenchao Sheng, Yingzi Cai, et al.
Journal of Attention Disorders (2024) Vol. 28, Iss. 11, pp. 1425-1436
Closed Access | Times Cited: 3
HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study
Kang Qu, Mingxi Li, Peng Yu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
No causal association between allergic rhinitis and migraine: a Mendelian randomization study
Hao Lv, Kunyu Liu, Yulie Xie, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Circulating lipids, lipid-lowering drug targets, and breast cancer risk: Comprehensive evidence from Mendelian randomization and summary data-based Mendelian randomization
Zhongxu Zhang, Daxin Zhang
Cancer Causes & Control (2024) Vol. 35, Iss. 6, pp. 983-994
Closed Access | Times Cited: 1
Novel insights into causal effects of serum lipids, lipid metabolites, and lipid-modifying targets on the risk of intracerebral aneurysm
Youjia Qiu, Bingyi Song, Ziqian Yin, et al.
European Stroke Journal (2024)
Open Access | Times Cited: 1
The Association between Statin Use and Reduced Migraine Likelihood: A Comprehensive Analysis of Migraine Subtypes and Statin Types in a Nationwide Korean Cohort
Ho Suk Kang, Joo Hee Kim, Ji Hee Kim, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1056-1056
Open Access | Times Cited: 1
Sarcopenia and immune-mediated inflammatory diseases: Evaluating causality and exploring therapeutic targets for sarcopenia through Mendelian randomization
Qijun Wang, Xuan Zhao, Shuai-Kang Wang, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113687-113687
Open Access | Times Cited: 1
Genetic association of lipids and lipid-lowering drug targets with the risk of type 1 diabetes and its complications
Haocheng Wang, Zirui Liu, Zhengkai Yang, et al.
Research Square (Research Square) (2024)
Open Access
Lipids, lipid-lowering drug target genes and pancreatic cancer: a Mendelian randomization study
Yuxuan Zhan, Kai Zhang, Yiqun Fan, et al.
Research Square (Research Square) (2024)
Closed Access
Lipids, lipid-lowering drugs and lateral epicondylitis of the humerus: a drug-targeted Mendelian randomization study
Meng-Meng Liu, Xiang Chen, Xiaohang Bao, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Assessing the effects of HMGCR, LPL, and PCSK9 inhibition on sleep apnea: Mendelian randomization analysis of drug targets
Wei Tan, Xiujuan Deng, Xiaoning Tan, et al.
Medicine (2024) Vol. 103, Iss. 43, pp. e40194-e40194
Open Access
The role of digital device use on the risk of migraine: a univariable and multivariable Mendelian randomization study
Zhiyi He, Fan Qiu, Jing Yang, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access
Gender-specific inflammatory burden and headache risk in youth: a NHANES analysis
Binbin Zhu, Rui Zhao, Long Wang, et al.
Head & Face Medicine (2024) Vol. 20, Iss. 1
Open Access
Genetic correlation between genes targeted by lipid-lowering drugs and venous thromboembolism: A drug-target Mendelian randomization study
Min Li, Hangyu Duan, Jinwen Luo, et al.
Medicine (2024) Vol. 103, Iss. 51, pp. e40770-e40770
Open Access
Page 1

Scroll to top